Cytori Cell Research Institute,Inc. Logo

Cytori Cell Research Institute,Inc.

Develops cell therapy medical devices using a patient's own adipose tissue.

3750 | T

Overview

Corporate Details

ISIN(s):
JP3426500009
LEI:
Country:
Japan
Address:
千代田区麹町2丁目3番3号

Description

ADR120S, Inc., formerly Cytori Cell Research Institute, Inc., is a company specializing in regenerative medicine. It focuses on the research, development, production, and sale of cell therapy-related medical devices. The company's core technology is the Celution® System, which processes a patient's own adipose (fat) tissue to isolate and concentrate Adipose-Derived Regenerative Cells (ADRCs). This proprietary platform is designed to enable safe and effective treatments for a variety of diseases and conditions with limited therapeutic options, such as osteoarthritis, chronic wounds, and Crohn's disease. The company aims to develop therapies that repair injured tissue, modify disease progression, and improve patient quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 08:04
確認書
Japanese 8.6 KB
2025-11-14 08:03
半期報告書-第22期(2025/04/01-2026/03/31)
Japanese 194.2 KB
2025-11-07 07:42
確認書
Japanese 8.3 KB
2025-11-07 07:39
訂正有価証券報告書-第21期(2024/04/01-2025/03/31)
Japanese 597.9 KB
2025-07-01 04:31
臨時報告書
Japanese 24.3 KB
2025-06-27 09:17
確認書
Japanese 8.2 KB
2025-06-27 09:16
有価証券報告書-第21期(2024/04/01-2025/03/31)
Japanese 946.5 KB
2025-06-27 09:16
内部統制報告書-第21期(2024/04/01-2025/03/31)
Japanese 23.7 KB
2025-05-30 02:01
臨時報告書
Japanese 20.1 KB
2025-02-10 08:41
臨時報告書
Japanese 20.5 KB
2025-01-06 08:19
臨時報告書
Japanese 19.0 KB
2024-11-14 08:06
確認書
Japanese 8.1 KB
2024-11-14 08:05
半期報告書-第21期(2024/04/01-2025/03/31)
Japanese 190.1 KB
2024-09-24 09:07
臨時報告書
Japanese 19.8 KB
2024-07-29 08:30
臨時報告書
Japanese 21.5 KB

Automate Your Workflow. Get a real-time feed of all Cytori Cell Research Institute,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cytori Cell Research Institute,Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cytori Cell Research Institute,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.